LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
29.37
+3.03 (11.50%)
At close: May 12, 2025, 4:00 PM
29.37
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
LENZ Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for LENZ Therapeutics stock have an average target of 41.8, with a low estimate of 36 and a high estimate of 51. The average target predicts an increase of 42.32% from the current stock price of 29.37.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LENZ Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +29.38% | May 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +2.15% | Apr 16, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $38 → $51 | Buy | Maintains | $38 → $51 | +73.65% | Apr 14, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $44 → $47 | Strong Buy | Maintains | $44 → $47 | +60.03% | Mar 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +29.38% | Nov 7, 2024 |
Financial Forecast
Revenue This Year
7.78M
Revenue Next Year
50.17M
from 7.78M
Increased by 544.90%
EPS This Year
-3.06
from -2.34
EPS Next Year
-2.89
from -3.06
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 11.9M | 59.6M | 147.0M |
| Avg | 7.8M | 50.2M | 126.4M |
| Low | 5.9M | 40.9M | 102.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 665.8% | 193.0% |
| Avg | - | 544.9% | 151.9% |
| Low | - | 425.3% | 105.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.65 | -2.22 | 0.17 |
| Avg | -3.06 | -2.89 | -0.86 |
| Low | -4.23 | -3.81 | -1.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.